UK Won't Introduce a Wealth Tax, Government Minister Says
'We're not going to do anything daft like that,' Business Secretary Jonathan Reynolds told GB News on Friday. 'I say to people: 'Be serious about this.''
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
6 minutes ago
- Yahoo
Evonik Industries Second Quarter 2025 Earnings: Misses Expectations
Evonik Industries (ETR:EVK) Second Quarter 2025 Results Key Financial Results Revenue: €3.50b (down 11% from 2Q 2024). Net income: €120.0m (up from €5.00m loss in 2Q 2024). Profit margin: 3.4% (up from net loss in 2Q 2024). EPS: €0.26 (up from €0.011 loss in 2Q 2024). We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free. All figures shown in the chart above are for the trailing 12 month (TTM) period Evonik Industries Revenues and Earnings Miss Expectations Revenue missed analyst estimates by 5.4%. Earnings per share (EPS) also missed analyst estimates by 31%. Looking ahead, revenue is forecast to grow 2.5% p.a. on average during the next 3 years, compared to a 3.4% growth forecast for the Chemicals industry in Germany. Performance of the German Chemicals industry. The company's shares are down 9.6% from a week ago. Risk Analysis Be aware that Evonik Industries is showing 2 warning signs in our investment analysis and 1 of those is significant... Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
6 minutes ago
- Yahoo
Down 55% in 5 years, but this FTSE stock offers a 9.5% dividend yield for income investors!
When it comes to high dividend yields, few FTSE stocks come close to beating Ashmore Group's (LSE:ASHM) current 9.5% payout. This yield's largely been driven by management maintaining dividends despite its share price tumbling by more than 50% over the last five years. So if dividends are seemingly here to stay, is this secretly a lucrative opportunity for income investors? The bull case Ashmore's share price weakness since 2020 has been driven predominantly by poor returns within emerging markets. As an investment specialist in this field, performance has suffered greatly as economically weaker countries struggled to handle both the impact of the pandemic and the subsequent macroeconomic headwinds that followed. Consequently, clients started withdrawing their capital, resulting in significant profit and revenue pressure on the business. However, emerging markets have since started rebounding quite significantly. In fact, the MSCI Emerging Market Index is up over 17% in the last 12 months. A weaker US dollar has been quite handy in helping emerging economies get back on their feet. And with businesses reporting recovering growth and earnings, these international stocks have followed suit. This has translated into the outflow of Ashmore's assets under management (AUM) to slow and stabilise. While profits are still significantly below 2021 levels, the firm's cash flow generation remains strong. Hence why management's been able to maintain dividends in spite of all the headwinds. And if emerging markets continue to outperform, Ashmore should have little trouble attracting investors back into the fold. What could go wrong? Even with improving external market conditions, there are still some notable risks that might jeopardise today's impressive dividend yield. Rising geopolitical tensions and conflict escalations could derail the recovery progress made in certain key emerging markets. And even if Ashmore successfully avoids these regions, weak sentiment from risk-adverse investors could still prevent the businesses from delivering strong returns. This scenario is particularly concerning given management is paying out more in dividends than it's actually generating from operations. In the long run, this is unsustainable, likely leading to a dividend cut if AUM and subsequently cash flows don't improve in the short term. Management does have a bit of wiggle room here with around £308m in cash & equivalents on the balance sheet and negligible levels of debts & equivalents. But the general consensus among institutional investors is that unless earnings can recover significantly within the next 18 months, a dividend cut could be unavoidable. The bottom line Ashmore's cyclical downturn appears to have finally reached the bottom with early signs of a recovery starting to kick off. However, there's still a lot of uncertainty regarding how long the recovery will take. And with more money flowing out of the business than coming in, the clock's ticking before management may be forced to cut shareholder payouts. Put simply, this is a very high-risk, high-reward income opportunity in 2025. But, with the business largely dependent on emerging market momentum – something outside of its control – this isn't a risk I'm willing to take. As such, investors may want to consider exploring other high-dividend yield stocks for their portfolios. The post Down 55% in 5 years, but this FTSE stock offers a 9.5% dividend yield for income investors! appeared first on The Motley Fool UK. More reading 5 Stocks For Trying To Build Wealth After 50 One Top Growth Stock from the Motley Fool Zaven Boyrazian has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors. Motley Fool UK 2025 Sign in to access your portfolio
Yahoo
6 minutes ago
- Yahoo
MEDICLIN Second Quarter 2025 Earnings: EPS: €0.20 (vs €0.04 in 2Q 2024)
MEDICLIN (ETR:MED) Second Quarter 2025 Results Key Financial Results Revenue: €203.4m (up 8.6% from 2Q 2024). Net income: €9.88m (up 395% from 2Q 2024). Profit margin: 4.9% (up from 1.1% in 2Q 2024). The increase in margin was driven by higher revenue. EPS: €0.20 (up from €0.04 in 2Q 2024). We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free. All figures shown in the chart above are for the trailing 12 month (TTM) period MEDICLIN Earnings Insights Looking ahead, revenue is forecast to stay flat during the next 3 years compared to a 4.0% growth forecast for the Healthcare industry in Germany. Performance of the German Healthcare industry. The company's shares are up 2.0% from a week ago. Risk Analysis We don't want to rain on the parade too much, but we did also find 1 warning sign for MEDICLIN that you need to be mindful of. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
